Immunome Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2019 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Immunome Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2019 to Q4 2024.
- Immunome Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$80.2M, a 13.4% increase year-over-year.
- Immunome Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$293M, a 174% decline year-over-year.
- Immunome Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$293M, a 174% decline from 2023.
- Immunome Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$107M, a 189% decline from 2022.
- Immunome Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$36.9M, a 49.3% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)